• 1
  • 2
  • Favorite

ADMA Biologics President and CEO Adam S. Grossman Reports Sale of $288,120 in Common Shares

Reuters10:02

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Report

Comment(2)

  • moliya
    ·11:12
    ADMA Biologics President and CEO Adam S. Grossman sold 21,000 common shares at $13.72 each on November 16, 2026. Grossman also exercised stock options to acquire 15,000 common shares at $5.4 each. His direct beneficial ownership totaled 2,064,777 common shares following the transactions.
    Reply
    Report
  • moliya
    ·11:11
    So insider trade If president sold 288.xxx shares @13xxx and placed option to buy at $5.4 then something going to happen
    Reply
    Report
 
 
 
 

Most Discussed

 
 
 
 
 

7x24